KRAS mutation testing in human cancers: The pathologist's role in the era of personalized medicine

HL Wang, J Lopategui, MB Amin… - Advances in anatomic …, 2010 - journals.lww.com
A number of studies have shown that although antiepidermal growth factor receptor (EGFR)
monoclonal antibodies are effective treatments for metastatic colorectal cancer (mCRC), …

[HTML][HTML] Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method

…, A Riley-Portuguez, F Chung, J Lopategui… - Modern …, 2009 - nature.com
Patients with advanced pulmonary adenocarcinoma exhibiting overexpression or mutation
of epidermal growth factor receptor tend to respond better to targeted therapy with tyrosine …

Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature

AK Wong, J Lopategui, S Clancy… - The American journal …, 2008 - journals.lww.com
Primary lymphomas of the breast are rare and predominately of B-cell phenotype.
Anaplastic large cell lymphoma is a T-cell lymphoma that accounts for only 3% of all non-Hodgkin …

Analysis of genomic characteristics and transmission routes of patients with confirmed SARS-CoV-2 in Southern California during the early stage of the US COVID-19 …

…, SS Chen, JT Kim, J Song, J Lopategui… - JAMA network …, 2020 - jamanetwork.com
Importance In late December 2019, an outbreak of a novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China. Data on the routes of …

[HTML][HTML] Next-generation sequencing: a novel approach to distinguish multifocal primary lung adenocarcinomas from intrapulmonary metastases

…, T Mudalige, Z Liu, N Deng, J Lopategui - The Journal of Molecular …, 2017 - Elsevier
Distinguishing between multiple lung primary tumors and intrapulmonary metastases is
imperative for accurate staging. The American Joint Committee on Cancer (AJCC) criteria are …

Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis

…, V Datta, J Lopategui… - Genes …, 2013 - Wiley Online Library
Langerhans cell histiocytosis (LCH) is a well‐known but rare disease that may occur at any
age with markedly variable clinical features: self‐regressive, localized, multiorgan, …

Recommendations for cell-free DNA assay validations: a joint consensus recommendation of the Association for Molecular Pathology and College of American …

…, CD Gocke, M Hameed, D Jordan, JR Lopategui… - The Journal of Molecular …, 2023 - Elsevier
Diagnosing, selecting therapy for, and monitoring cancer in patients using a minimally invasive
blood test represents a significant advance in precision medicine. Wide variability exists …

Detection of Epstein-Barr viral RNA in sinonasal undifferentiated carcinoma from Western and Asian patients

JR Lopategui, MJ Gaffey, HF Frierson… - The American journal …, 1994 - journals.lww.com
Undifferentiated carcinoma of the nasopharynx has a well-known association with Epstein-Barr
virus (EBV), but only an inconsistent relationship has been identified in undifferentiated …

Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas

M Cinar, F Rosenfelt, S Rokhsar, J Lopategui, R Pillai… - Leukemia research, 2015 - Elsevier
Double hit lymphoma or triple hit lymphoma (DHL/THL) is a rare form of aggressive B-Cell
Lymphoma. Overexpression of MYC, BCL2 or/and BCL6 due to genomic rearrangements are …

Comparison of large, medium, and small solid tumor gene panels for detection of clinically actionable mutations in cancer

…, A Mita, M Mita, RA Figlin, DM Engman, JR Lopategui - Targeted Oncology, 2020 - Springer
Background Next-generation sequencing of gene panels has supplanted single-gene
testing for cancer molecular diagnostics in many laboratories. Considerations for the optimal …